Index of artpub/2024/311669/

Leary, Alexandra
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
2024
https://ddd.uab.cat/record/311669